Back to Newsroom

Novavax to Participate in Multiple Investor Conferences in September

GAITHERSBURG, Md., Sept. 02, 2015 (GLOBE NEWSWIRE) — Novavax, Inc., (Nasdaq:NVAX) a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced the Company will participate in the FBR 2nd Annual Healthcare Conference and the Citi 10th Annual Biotech Conference.

Click here to read more